Double vs. single cord blood transplantation in adolescent and adult hematological malignancies with heavier body weight (≥50 kg)

References

• Sideri A, Neokleous N, Brunet De La Grange P, et al. An overview of the progress on double umbilical cord blood transplantation. Haematologica. 2011;96(8):1213–1220. doi: 10.3324/haematol.2010.038836
   PubMed Web of Science ®Google Scholar
• Verneris MR, Brunstein CG, Barker J, et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood. 200;114(19):4293–4299. doi: 10.1182/blood-2009-05-220525
   Google Scholar
• Labopin M, Ruggeri A, Gorin NC, et al. Eurocord and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France. Haematologica. 2014;99(3):535–540. doi: 10.3324/haematol.2013.092254
   PubMed Web of Science ®Google Scholar
• Bradstock K, Hertzberg M, Kerridge I, et al. Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes. Intern Med J. 2009;39(11):744–751. doi: 10.1111/j.1445-5994.2008.01825.x
   PubMed Web of Science ®Google Scholar
• Tsang KS, Leung AW, Lee V, et al. Indiscernible benefit of double-unit umbilical cord blood transplantation in children: a single-center experience from Hong Kong. Cell Transplant. 2016;25(7):1277–1286. doi: 10.3727/096368915X689631
   PubMed Web of Science ®Google Scholar
• Wagner JE, Jr, Eapen M, Carter S, et al. Blood and marrow transplant clinical trials network. One-unit versus two-unit cord-blood transplantation for hematologic cancers. N Engl J Med. 2014;371(18):1685–1694. doi: 10.1056/NEJMoa1405584
   PubMed Web of Science ®Google Scholar
• Michel G, Galambrun C, Sirvent A, et al. Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome. Blood. 2016;127(26):3450–3457. doi: 10.1182/blood-2016-01-694349
   PubMed Web of Science ®Google Scholar
• Scaradavou A, Brunstein CG, Eapen M, et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood. 2013;121(5):752–758. doi: 10.1182/blood-2012-08-449108
   PubMed Web of Science ®Google Scholar
• Zheng C, Zhu X, Tang B, et al. The impact of pre-transplant minimal residual disease on outcome of intensified myeloablative cord blood transplant for acute myeloid leukemia in first or second complete remission. Leuk Lymphoma. 2016;57(6):1398–1405. doi: 10.3109/10428194.2015.1102241
   PubMed Web of Science ®Google Scholar
• Zheng C, Zhu X, Tang B, et al. Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia. Ann Hematol. 2015;94(3):473–480. doi: 10.1007/s00277-014-2213-y
   PubMed Web of Science ®Google Scholar
• Zheng C, Tang B, Yao W, et al. Comparison of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in advanced stage. Biol Blood Marrow Transplant. 2013;19(12):1708–1712. doi: 10.1016/j.bbmt.2013.09.008
   PubMed Web of Science ®Google Scholar
• Dignan FL, Clark A, Amrolia P, et al. Haemato-oncology task force of British committee for standards in haematology; British society for blood and marrow transplantation. diagnosis and management of acute graft-versus-host disease. Br J Haematol. 2012;158:30–45. doi: 10.1111/j.1365-2141.2012.09129.x
   PubMed Web of Science ®Google Scholar
• Dignan FL, Amrolia P, Clark A, et al. Haemato-oncology task force of British committee for standards in haematology; British society for blood and marrow transplantation. diagnosis and management of chronic graft-versus-host disease. Br J Haematol2012;158:46–61. doi: 10.1111/j.1365-2141.2012.09128.x
   PubMed Web of Science ®Google Scholar
• Holtan SG, DeFor TE, Lazaryan A, et al. Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood. 2015;125:1333–1338. doi: 10.1182/blood-2014-10-609032
   PubMed Web of Science ®Google Scholar
• Haspel RL, Ballen KK. Double cord blood transplants: filling a niche? Stem Cell Rev. 2006;2(2):81–86.
   PubMedGoogle Scholar
• Scaradavou A, Smith KM, Hawke R, et al. Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation. Biol Blood Marrow Transplant. 2010;16(4):500–508. doi: 10.1016/j.bbmt.2009.11.013
   PubMed Web of Science ®Google Scholar
• Newell LF, Milano F, Nicoud IB, et al. Early CD3 peripheral blood chimerism predicts the long-term engrafting unit following myeloablative double-cord blood transplantation. Biol Blood Marrow Transplant. 2012;18(8):1243–1249. doi: 10.1016/j.bbmt.2012.01.014
   PubMed Web of Science ®Google Scholar
• Ramirez P, Wagner JE, DeFor TE, et al. Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transplant. 2012;47(6):799–803. doi: 10.1038/bmt.2011.184
   PubMed Web of Science ®Google Scholar
• Saliba RM, Rezvani K, Leen A, et al. General and virus-specific immune cell reconstitution after double cord blood transplantation. Biol Blood Marrow Transplant. 2015;21(7):1284–1290. doi: 10.1016/j.bbmt.2015.02.017
   PubMed Web of Science ®Google Scholar
• Kanda J, Morishima Y, Terakura S, et al. Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation. Leukemia. 2017;31(3):663–668. doi: 10.1038/leu.2016.288
   PubMed Web of Science ®Google Scholar